CMS says the 18-month demonstration will expand access to select weight-loss drugs while the agency gathers data on uptake, outcomes and program operations.
NeuroX, a neurology-focused online consultation service, and its physician network ATP Partners announced it will participate in the Centers for Medicare and Medicaid Services (CMS) GUIDE Program to ...
Eli Lilly (LLY) stock and Novo Nordisk (NVO) stock are in focus as Medicare offers coverage for GLP-1 weight-loss drugs for ...
JACKSON, Wyo.--(BUSINESS WIRE)--Remo Health, a virtual dementia care provider for patients and their family caregivers, is proud to announce its acceptance into the Centers for Medicare and Medicaid ...
Millions of people with Medicare are now eligible to get discounted GLP-1 drugs for weight loss under a special program. Here's how it will work.
Papa, the category-defining innovator and national leader in in-home support, today announced partnerships with Tembo Health and AVVACare as an Approved Partner Organization within the Centers for ...
The University of Utah Aging Brain Care Clinic is participating in GUIDE. GUIDE is a model introduced by the Centers for Medicare and Medicaid Services (CMS) to promote improved dementia care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results